LHDX News and Press, Lucira Health Inc. From 09/29/22

EMERYVILLE, Calif., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) (“Lucira Health” or “Lucira”), a medical technology company, today announced interim results of a pilot study to evaluate the performance of their combined Chlamydia trach...

EMERYVILLE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, and a digit...

Gainers: Artelo Biosciences ( ARTL ) +31% . Ventyx Biosciences ( VTYX ) +23% . Eargo ( EAR ) +19% . Fulcrum Therapeutics ( FULC ) +18% . Genprex ( GNPX ) +17% . Losers: Albireo Pharma ( ALBO ) -25% . Sema4...

Lucira Health, Inc. (LHDX) Q2 2022 Earnings Conference Call August 15, 2022 4:30 PM ET Company Participants Louisa Smith – Investor Relations Erik Engelson – President and Chief Executive Officer Dan George – Chief Financial Officer and Treas...

Image source: The Motley Fool. Lucira Health, Inc. (NASDAQ: LHDX) Q2 2022 Earnings Call Aug 15, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Lucira Health, Inc. (LHDX) Q2 2022 Earnings Call Transcript

Lucira Health press release ( NASDAQ: LHDX ): Q2 GAAP EPS of $0.54 beats by $0.93 . Revenue of $26.1M (+109.8% Y/Y) misses by $2.33M . Cash and Cash Equivalents Balance as of June 30, 2022 was $75.0 million. For further details see: Lucira Hea...

EMERYVILLE, Calif., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease tests, today reported fina...

Lucira Health ( NASDAQ: LHDX ) said Health Canada granted authorization for emergency use and commercialization of the company's at-home test for COVID and Flu. The Lucira COVID-19 & Flu Test is a 99% accurate rapid molecular test which delivers results in 30 ...

EMERYVILLE, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease tests, today announced tha...

EMERYVILLE, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced t...